Palo Alto Investors »

Nevro shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Nevro (NVRO) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Nevro

Tip: Access up to 7 years of quarterly data

All positions including Nevro held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nevro by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 750k 21.52
2023-09-30 $7.4M 387k 19.22
2023-06-30 $4.7M 186k 25.42

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Biogen Idec (BIIB)
United Therapeutics Corporation (UTHR)
ACADIA Pharmaceuticals (ACAD)
Prothena Corp SHS (PRTA)
Revance Therapeutics (RVNC)
Staar Surgical Com Par $0.01 (STAA)
Alnylam Pharmaceuticals (ALNY)
eHealth (EHTH)
Sage Therapeutics (SAGE)
Sarepta Therapeutics (SRPT)
Iovance Biotherapeutics (IOVA)
Alkermes SHS (ALKS)

View all positions for Palo Alto Investors

Top funds holding Nevro

Vanguard Group
Arrowpoint Asset Management
Engaged Capital
Fred Alger Management
Braidwell
D. E. Shaw & Co
Goldman Sachs Group
Millennium Management
Palo Alto Investors
Principal Financial Group
Balyasny Asset Management
Two Sigma Advisers
Two Sigma Investments
Federated Investors
Credit Suisse

View all funds holding Nevro